SCHEMBL27047

SCHEMBL27047

CCC=C(OCC)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
HCAR2 Q8TDS4 1/20 0.41
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALOX15 P16050 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
TRPA1 O75762 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
GLO1 Q04760 1/20 0.35
CYP2D6 P10635 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GRIK1 P39086 1/20 0.35
GRIK2 Q13002 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
EGLN1 Q9GZT9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43125 1.00 ALDH1A1 (0.42) ALDH1A1HCAR2LMNAHSD17B10ALOX15
Butylamine SCHEMBL11489838 0.85 CYP1A2 (0.43) ALDH1A1HCAR2ALOX15GRIK1GRIK2
SCHEMBL9632867 0.82 GRIK1 (0.39) ALDH1A1HCAR2LMNAHSD17B10ALOX15
SCHEMBL642905 0.82 GRIK1 (0.39) ALDH1A1HCAR2LMNAHSD17B10ALOX15
SCHEMBL5165049 0.82 HCAR2 (0.45) ALDH1A1HCAR2LMNAGAASMN1; SMN2
SCHEMBL246020 0.81 ALDH1A1 (0.50) ALDH1A1HCAR2HSD17B10SMN1; SMN2GRIK1
SCHEMBL27823568 0.81 ALDH1A1 (0.50) ALDH1A1HCAR2HSD17B10SMN1; SMN2GRIK1
SCHEMBL28294404 0.81 ALDH1A1 (0.46) ALDH1A1HCAR2LMNAHSD17B10ALOX15
SCHEMBL27715620 0.81 NPSR1 (0.45) ALDH1A1HCAR2LMNAHSD17B10ALOX15
SCHEMBL8982150 0.80 TSHR (0.39) ALDH1A1HCAR2HSD17B10GAAGRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4214253-A1 ULTRAVIOLET-ABSORBING ACRYLIC COPOLYMER FOR THE PRODUCTION OF FLEXIBLE INTRAOCULAR LENS Acrylian (FR) 2023-07-26 EP claimed
WO-2022058240-A1 ULTRAVIOLET-ABSORBING ACRYLIC COPOLYMER FOR THE PRODUCTION OF FLEXIBLE INTRAOCULAR LENS TERRISSE JEAN (FR) 2022-03-24 WO claimed
EP-2757133-B1 UV-CURABLE INK FOR DIRECT PLATE MAKING BY INK-JET PRINTING WITH PREPARATION METHOD AND APPLICATION THEREFOR INST CHEMISTRY CAS (CN) 2016-12-28 EP claimed
EP-2807026-A1 MULTILAYER SYSTEMS LANXESS Deutschland GmbH (DE) 2014-12-03 EP claimed
WO-2013110610-A1 MULTILAYER SYSTEMS LANXESS DEUTSCHLAND GMBH (DE) 2013-08-01 WO claimed
EP-2620277-A1 Multi-layer systems LANXESS Deutschland GmbH (DE) 2013-07-31 EP claimed
EP-0135971-B1 METHOD OF OPTICALLY CONNECTING A LIGHT CONDUCTOR TO AN ELECTRO-OPTICAL DEVICE Koninklijke Philips Electronics N.V. (NL) 1988-07-27 EP claimed
CN-85102118-A The optical glass fibre of coat of synthetic resin and manufacture method thereof 1987-01-31 CN claimed
EP-0135971-A2 Method of optically connecting a light conductor to an electro-optical device Koninklijke Philips Electronics N.V. (NL) 1985-04-03 EP claimed
WO-2024245839-A1 STABILIZATION OF URETHANE HYBRID RESIN SYSTEMS COVESTRO DEUTSCHLAND AG (DE) 2024-12-05 WO disclosed
EP-4467587-A1 STABILIZATION OF URETHANE HYBRID RESIN SYSTEMS Covestro Deutschland AG (DE) 2024-11-27 EP disclosed
EP-4214253-A1 ULTRAVIOLET-ABSORBING ACRYLIC COPOLYMER FOR THE PRODUCTION OF FLEXIBLE INTRAOCULAR LENS Acrylian (FR) 2023-07-26 EP disclosed
WO-2022058240-A1 ULTRAVIOLET-ABSORBING ACRYLIC COPOLYMER FOR THE PRODUCTION OF FLEXIBLE INTRAOCULAR LENS TERRISSE JEAN (FR) 2022-03-24 WO disclosed
EP-3755735-A1 POLYURETHANE-BASED POLYMER MATERIAL HAVING EXCELLENT RESISTANCE TO HEAT DISTORTION AND ELONGATION AT TEAR BASF SE (DE) 2020-12-30 EP disclosed
WO-2010012736-A1 PROCESS FOR PRODUCING POLYURETHANE-BASED TENNIS BALLS BASF SE (DE) 2010-02-04 WO disclosed
US-20090246390-A1 ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH AZIRIDINE CROSSLINKING AGENTS 3M INNOVATIVE PROPERTIES COMPANY 2009-10-01 US disclosed
WO-2009063004-A2 FOAMED POLYURETHANES HAVING IMPROVED FLEXURAL ENDURANCE PROPERTIES BASF SE (DE) 2009-05-22 WO disclosed
US-5177116-A Polysiloxane BASF CORPORATION (US) 1993-01-05 US disclosed
EP-0135971-B1 METHOD OF OPTICALLY CONNECTING A LIGHT CONDUCTOR TO AN ELECTRO-OPTICAL DEVICE Koninklijke Philips Electronics N.V. (NL) 1988-07-27 EP disclosed
EP-0135971-A2 Method of optically connecting a light conductor to an electro-optical device Koninklijke Philips Electronics N.V. (NL) 1985-04-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090246390-A1 ACRYLIC PRESSURE-SENSITIVE ADHESIVES WITH AZIRIDINE CROSSLINKING AGENTS AAAS, CDH1, PTK2 ALDH1A1 698/4885HCAR2 1649/4885LMNA 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.